Clinical TrialsSearch results
Number of results: 67036
Not yet recruiting
- A study of meal intake rate measurement methods and differences between different types of meals
- normal subjects
- Fujita health university
- 2024-05-27
Not yet recruiting
- Association between ICG R/K and biliary anatomy visualization by intraoperative fluorescene cholangiography
- cholecystolithiasis, acute cholecystitis, chronic cholecystitis, gallbladder polyps
- Tajimi Municipal Hospital
- 2024-05-27
Not yet recruiting
- Examining the safety and effectiveness of mental health care apps for young people with depressive symptoms
- Depressive symptoms
- Ide Keiko
- 2024-05-27
Not yet recruiting
- Investigation of the relationship between organic light-emitting diode (OLED) lighting and fatigue or health
- Adult
- Osaka Metropolitan University
- 2024-05-27
Not yet recruiting
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- APS, BP, BS, DM, IMNM, and ITP (Please refer to "Others" section for abbreviations)
- Hashimoto Akiko
- 2024-05-27
Not yet recruiting
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (ASCENT)
- Neovascular age-related macular degeneration
- Tetsuya Otani
- 2024-05-27
Not yet recruiting
- Platform to Evaluate the Safety and Efficacy of post-exposure prophylaxis for viral hemorrhagic fevers sub-protocol 01:Remdesivir for patients exposed to Ebora virus
- Prevention of the onset of Ebola virus and Ebola hemorrhagic fever in persons exposed to Ebola patie
- Morioka Shinichiro
- 2024-05-27
Not yet recruiting
- Platform to Evaluate the Safety and Efficacy of post-exposure prophylaxis for viral hemorrhagic fevers sub-protocol 02:Favipiravir for patients exposed to Lassa virus
- Prevention of the onset of Lassa virus or Lassa fever in persons exposed to patients with Lassa viru
- Morioka Shinichiro
- 2024-05-27
Not yet recruiting
- Platform to Evaluate the Safety and Efficacy of Treatments for Mpox or Smallpox. sub-protocol01 Tecovirimat
- Mpox, Smallpox
- Morioka Shinichiro
- 2024-05-27
Not yet recruiting
- Platform to Evaluate the Safety and Efficacy of Treatments for Viral Hemorrhagic Fevers sub-protocol 01: REGN-EB3 for Ebora Virus Patients
- Ebora Virus
- Morioka Shinichiro
- 2024-05-27